Comprehend Clinical Releases New Clinical Reporting and Visualization Software
Comprehend Systems, Inc., the makers of Comprehend Clinical, will be offering live demonstrations of the new version of their software at the Drug Information Association's 47th Annual Meeting, DIA 2011, to be held in Chicago on June 19-23, 2011. Comprehend Clinical is a next-generation web-based reporting and visualization platform which makes it easier to understand, explore, and analyze clinical data by allowing end-users to access multiple data sources simultaneously.
"It is a hybrid ETL and reporting and visualization tool that leverages the power of existing CDMS, EDC, and other clinical data systems," said Rick Morrison, CEO and Co-founder of Comprehend Systems, Inc. Live demonstrations in Booth 502 at DIA 2011 will showcase how Comprehend Clinical can facilitate real-time decision making for data managers, clinicians, clinical monitors, and executives.
Listen to Rick Morrison discuss analytics in clinicaltrials further here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
